New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
March 6, 2025 - Neurotech announced the FDA approval of Encelto (revakinagene taroretcel-lwey), for the treatment of adults with idiopathic macular telangiectasia type 2 (MacTel).
Download PDF
Return to publications
